Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis
ConclusionReal-world evidence suggests a persistence benefit for patients with IPF treated with nintedanib who are enrolled in the patient support program.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | Learning | Study | Universities & Medical Training